GeoVax Labs (GOVX) Earnings Date & Reports

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GOVX is expected to report earnings to fall 95.35% to -22 cents per share on March 21

Q4'23

Est.

$-0.22

Q3'23

Missed

by $4.60

Q2'23

Missed

by $0.05

Q1'23

Missed

by $2.05

Q4'22

Missed

by $0.63

The last earnings report on November 08 showed earnings per share of -480 cents, missing the estimate of -20 cents. With 446.47K shares outstanding, the current market capitalization sits at 10.29M.

View a ticker or compare two or three

Compare

GOVX